FSCN1 and carcinoid tumor: Positive FSCN1 expression is detected in 5% of typical carcinoid tumors, 35% of atypical carcinoid tumors, 83% of large-cell neuroendocrine lung cancer, and 100% of small-cell lung cancer (Pelosi et al., 2003).